Clinical trials: Gastric Submucosal Tumors
Early Gastric Cancer, Colon Neoplasia
Magnetic Guided Counetrtraction During Endoscopic Submucosal Dissection
Endoscopic submucosal dissection (ESD) is a technique that allows curative treatment of early gastrointestinal neoplasia with organ preservation. However, it is a technically demanding procedure.
- Trial name
- NCT06962293
- Testing
- MAG-ESD assisted ESD
- Where
- Hong Kong
- Volunteers
- 20 people
- Sponsor
- Chinese University of Hong Kong
Delayed Bleeding
Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial
after endoscopic submucosal dissection(ESD) of early gastric cancer, conventional proton pump(PPI) inhibitors and H2 receptor antagonists have a controversial effect on preventing bleeding from artificial ulcers.
- Trial name
- NCT01179724
- Testing
- high dose proton pump inhibitor, H2RB
- Where
- South Korea
- Volunteers
- 206 people
- Sponsor
- Samsung Medical Center
Stomach Neoplasms
Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer
1. Introduction The aim of the study is to evaluate the efficacy and safety of ESD by use of a new water-jet assisted ESD system using the HybridKnife® in patients with early gastric neoplastic lesions in comparison to the…
- Trial name
- NCT01943253
- Testing
- Conventional ESD, Hybridknife ESD
- Where
- Germany
- Volunteers
- 117 people
- Sponsor
- Shanghai Zhongshan Hospital